Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Zomorph 10mg modified-release capsules
0407020Q0BKAAEF
|
Zomorph | Morphine sulfate | Central Nervous System | 105,887 |
|
Zomorph 30mg modified-release capsules
0407020Q0BKABEG
|
Zomorph | Morphine sulfate | Central Nervous System | 86,769 |
|
Zomorph 60mg modified-release capsules
0407020Q0BKACEH
|
Zomorph | Morphine sulfate | Central Nervous System | 30,371 |
|
Zomorph 100mg modified-release capsules
0407020Q0BKADEB
|
Zomorph | Morphine sulfate | Central Nervous System | 8,089 |
|
Zomorph 200mg modified-release capsules
0407020Q0BKAEEI
|
Zomorph | Morphine sulfate | Central Nervous System | 896 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.